Key Highlights
•
This study analyzed data from over 12,700 patients undergoing transcatheter aortic valve implantation (TAVI) globally, finding that 25% had a bicuspid aortic valve (BAV), with the highest prevalence in India (43%) and significant differences in valve morphology and annular size across regions. These geographical variations are critical for procedural planning and risk assessment in TAVI, as they may influence device selection and patient outcomes.
Source →
•
This review examines how adding targeted immunotherapy to transarterial chemoembolisation (TACE) significantly improves progression-free survival in intermediate-stage hepatocellular carcinoma, though overall survival benefits remain inconsistent. The findings highlight the urgent need for precision patient stratification using biomarkers like tumor burden, microvascular invasion, and immune status to guide combination therapies.
Source →
•
This study presents the final overall survival data from the POD1UM-303/InterAACT-2 trial, showing that the immunotherapy retifanlimab combined with carboplatin-paclitaxel significantly extended survival in patients with advanced squamous cell carcinoma of the anal canal. This represents a major step forward in clinical decision-making for a rare cancer with limited treatment options.
Source →
•
A new study using transposon-directed insertion-site sequencing identified key genes that allow Streptococcus dysgalactiae subspecies equisimilis (SDSE), an emerging pathogen, to cause severe necrotizing myositis in non-human primates. This research provides critical insight into the genetic mechanisms of this invasive infection, guiding future therapeutic targets and patient safety strategies.
Source →
•
This study found that telling potential Alzheimer’s disease research volunteers about financial compensation during recruitment may actually lower enrollment rates, possibly because it conflicts with altruistic motives. This has important implications for clinical trial recruitment strategies, suggesting that the timing and framing of compensation information can significantly impact evidence-based research participation.
Source →
Stay curious. Stay informed —
Science Briefing
